Not exact matches
Since 2000 Head of Lymphocyte Activation Unit Division of Immunology, Transplantation and Infectious Diseases Program in Immunology, Bio-Immuno-gene therapy of Cancer, IRCCS Ospedale San Raffaele, Milan, Italy 1998 - 1999
Research Associate Department of Molecular Biology and Functional Genomic, IRCCS Ospedale San Raffaele, Milan, Italy 1993 - 1998 Postdoctoral Associate Department of Microbiology University of Minnesota, Medical School Minneapolis, MN, USA 1991 - 1992 Department of Pharmacology, New York University, New York, USA 1989 - 1991 Department of Biomedical Science and
Oncology, Turin, Italy 1988 - 1989
Research Fellow Department of Biomedical Science and
Oncology, Turin, Italy 1989 - 1992 Ph.D. student in Molecular
Oncology 1986 - 1988 Undergraduate student Department of Biomedical Science and
Oncology, Turin, Italy
Dr. Bolen, the chief scientific officer and global head of
oncology research at Millennium: The Takeda Oncology Company has served in senior leadership positions at Millennium sin
oncology research at Millennium: The Takeda
Oncology Company has served in senior leadership positions at Millennium sin
Oncology Company has served in senior leadership positions at Millennium
since 1999.
Her prominence in the United States cancer
research community is embodied in the Dana - Farber Cancer Institute - based Physical Science -
Oncology Center, a collaborative, interdisciplinary endeavor that she has led
since 2009, thanks to a competitive $ 11 million grant she received from the National Cancer Institute; at the center, researchers apply physical sciences to solve problems in cancer biology.
Since 1990, Cohn has been a leader in national pediatric cooperative clinical
research groups, including serving as chair of the Pediatric
Oncology Group Neuroblastoma Biology Committee, chair of the Children's
Oncology Group (COG) Neuroblastoma Disease Committee, and director of the COG Neuroblastoma Tracking Center.
«The approval of ipilimumab to treat advanced metastatic melanoma is a game changer not only for the thousands of people fighting this disease, but also for the entire field of
oncology,» says Jill O'Donnell - Tormey, Ph.D., executive director of the Cancer
Research Institute (CRI), a nonprofit organization that
since 1953 has worked to advance the science of tumor immunology.
Jersey City Walk for comparative
oncology research, but Jude also enlisted Big Paws Pet Care for a Cause as the major sponsor of the event — that year and every year
since.